A perspective on Alzheimer's disease: exploring the potential of terminal/paradoxical lucidity and psychedelics.
Mol Neurodegener October 12, 2024 DOI: 10.1186/s13024-024-00761-5
Summary
Some Alzheimer's patients experience remarkable moments of mental clarity near death. This intriguing phenomenon, combined with emerging psychedelic research, suggests new possibilities for treating cognitive decline. Scientists propose that both end-of-life lucidity and psychedelics may work through similar brain mechanisms, potentially offering insights into memory access and cognitive function in dementia patients.
Abstract
A perspective on Alzheimer's disease: exploring the potential of terminal/paradoxical lucidity and psychedelics.